Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
Study of ORIC-101 in Combination With Anticancer Therapy

The purpose of this study is to establish the recommended Phase 2 dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of ORIC-101 in combination with nab-paclitaxel or other anticancer therapies when administered to patients with advanced or metastatic solid tumors.

measurable disease
cancer treatment
metastasis
solid tumor
paclitaxel
Florida Cancer Specialists & Research Institute
 (4.8 away) Contact site
  • 9 views
  • 22 Sep, 2021
  • +11 other locations
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Cancer (SERENA-1)

Research Site
 (5.4 away) Contact site
  • 84 views
  • 17 Sep, 2021
  • +17 other locations
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

This is a Phase 1 cohort, dose-escalation, dose-expansion study of PRT543 in patients with advanced cancers who have exhausted available treatment options. The purpose of this study is to define a safe dose and schedule to be used in subsequent development of PRT543.

Florida Cancer Specialist
 (5.4 away) Contact site
  • 80 views
  • 07 Aug, 2021
  • +22 other locations
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-2127 in patients with advanced B-cell malignancies.

b-cell lymphoma
progressive disease
monoclonal antibody therapy
prolymphocytic leukemia
b-cell small lymphocytic lymphoma
Sarah Cannon Research Institute at Florida Cancer Specialists
 (5.4 away) Contact site
  • 1 views
  • 18 Aug, 2021
  • +6 other locations
A Study of BTX-A51 in People With Advanced Solid Tumor or Non-Hodgkin Lymphoma

This is a multicenter, open label, nonrandomized, sequential dose escalation/cohort expansion, multiple dose study designed to evaluate the safety, toxicity, and PK as well as preliminary efficacy of BTX-A51 in subjects with advanced solid tumors and NHL. The study will be done in two phases, described below. Phase 1a (Dose …

solid tumor
Florida Cancer Specialists
 (5.4 away) Contact site
  • 0 views
  • 19 Jun, 2021
  • +2 other locations
Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

To evaluate the safety and tolerability, the antiviral activity, and plasma pharmacokinetics (PK) of zotatifin administered intravenously (IV) to adults with mild or moderate COVID-19.

Synergy Healthcare
 (7.0 away) Contact site
  • 0 views
  • 15 Aug, 2021
  • +3 other locations
Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

A Phase 1 Open-label Dose Escalation Trial of BDB018 in Monotherapy and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

Florida Cancer Specialists
 (5.4 away) Contact site
  • 0 views
  • 13 Aug, 2021
  • +3 other locations
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With BI 754091 to Patients With Advanced Solid Tumors Having the B7-H6 Marker

This study is open to adults with advanced solid tumors whose previous cancer treatment was not successful. People can participate if their tumor has the B7-H6 marker or if they have colorectal cancer. The study tests 2 medicines called BI 765049 and BI 754091. Both medicines may help the immune …

Florida Cancer Specialists
 (5.4 away) Contact site
  • 0 views
  • 16 Sep, 2021
  • +2 other locations
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

This clinical trial is evaluating a drug called SNX281 given by itself and in combination with pembrolizumab in participants with advanced solid tumors and lymphoma. The main goals of this study are to: Find the recommended dose of SNX281 that can be given to participants safely alone and in combination …

Florida Cancer Specialist
 (5.4 away) Contact site
  • 0 views
  • 18 Jul, 2021
  • +4 other locations
BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab

Phase 1 Open-Label Dose Escalation Study of BDB001 as a Single Agent and in combination with Pembrolizumab in Subjects with Advanced Solid Tumors

Florida Cancer Specialists
 (6.3 away) Contact site
  • 78 views
  • 12 Sep, 2021
  • +3 other locations